The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases von Stengel, A, Kern, W, Haferlach, T, Meggendorfer, M, Fasan, A, Haferlach, C

Volltext

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients von Jeromin, S, Weissmann, S, Haferlach, C, Dicker, F, Bayer, K, Grossmann, V, Alpermann, T, Roller, A, Kohlmann, A, Haferlach, T, Kern, W, Schnittger, S

Volltext

Landscape of TET2 mutations in acute myeloid leukemia von Weissmann, S, Alpermann, T, Grossmann, V, Kowarsch, A, Nadarajah, N, Eder, C, Dicker, F, Fasan, A, Haferlach, C, Haferlach, T, Kern, W, Schnittger, S, Kohlmann, A

Volltext

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes von Haferlach, T, Nagata, Y, Grossmann, V, Okuno, Y, Bacher, U, Nagae, G, Schnittger, S, Sanada, M, Kon, A, Alpermann, T, Yoshida, K, Roller, A, Nadarajah, N, Shiraishi, Y, Shiozawa, Y, Chiba, K, Tanaka, H, Koeffler, H P, Klein, H-U, Dugas, M, Aburatani, H, Kohlmann, A, Miyano, S, Haferlach, C, Kern, W, Ogawa, S

Volltext

The role of different genetic subtypes of CEBPA mutated AML von Fasan, A, Haferlach, C, Alpermann, T, Jeromin, S, Grossmann, V, Eder, C, Weissmann, S, Dicker, F, Kohlmann, A, Schindela, S, Kern, W, Haferlach, T, Schnittger, S

Volltext

How do I Diagnose MDS Using Currently Available Tools? von Haferlach, T

Volltext

STAT3 mutations are highly specific for large granular lymphocytic leukemia von Fasan, A, Kern, W, Grossmann, V, Haferlach, C, Haferlach, T, Schnittger, S

Volltext

Subtype-specific patterns of molecular mutations in acute myeloid leukemia von Rose, D, Haferlach, T, Schnittger, S, Perglerová, K, Kern, W, Haferlach, C

Volltext

Comprehensive genetic characterization of CLL : a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping von HAFERLACH, C, DICKER, F, SCHNITTGER, S, KERN, W, HAFERLACH, T

Volltext

Dreams can come true: the first steps toward a peripheral blood screening test for the early detection of tumors have been taken von Haferlach, C., Haferlach, T.

Volltext

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping von Haferlach, C, Dicker, F, Schnittger, S, Kern, W, Haferlach, T

Volltext

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis von Jawhar, M, Schwaab, J, Schnittger, S, Meggendorfer, M, Pfirrmann, M, Sotlar, K, Horny, H-P, Metzgeroth, G, Kluger, S, Naumann, N, Haferlach, C, Haferlach, T, Valent, P, Hofmann, W-K, Fabarius, A, Cross, N C P, Reiter, A

Volltext

Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML von Stengel, A, Kern, W, Meggendorfer, M, Nadarajah, N, Perglerovà, K, Haferlach, T, Haferlach, C

Volltext

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia von Meggendorfer, Manja, Haferlach, Torsten, Alpermann, Tamara, Jeromin, Sabine, Haferlach, Claudia, Kern, Wolfgang, Schnittger, Susanne

Volltext

Diagnostics of MPNs – to be or not to be? von Haferlach, T

Volltext

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations von Meggendorfer, M, Bacher, U, Alpermann, T, Haferlach, C, Kern, W, Gambacorti-Passerini, C, Haferlach, T, Schnittger, S

Volltext

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia von Schnittger, S, Bacher, U, Kern, W, Alpermann, T, Haferlach, C, Haferlach, T

Volltext

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype von Haferlach, C, Dicker, F, Herholz, H, Schnittger, S, Kern, W, Haferlach, T

Volltext

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status von Schmidt, M, Rinke, J, Schäfer, V, Schnittger, S, Kohlmann, A, Obstfelder, E, Kunert, C, Ziermann, J, Winkelmann, N, Eigendorff, E, Haferlach, T, Haferlach, C, Hochhaus, A, Ernst, T

Volltext

Landmark analysis of DNMT3A mutations in hematological malignancies von Roller, A, Grossmann, V, Bacher, U, Poetzinger, F, Weissmann, S, Nadarajah, N, Boeck, L, Kern, W, Haferlach, C, Schnittger, S, Haferlach, T, Kohlmann, A

Volltext